Open AccessRosuvastatin for the prevention of venous thromboembolism: a pooled analysis of the HOPE-3 and JUPITER randomized controlled trials
Author(s) -
Philip Joseph,
Robert J. Glynn,
Eva Lonn,
Chinthanie Ramasundarahettige,
John W. Eikelboom,
Jean MacFadyen,
Paul M. Ridker,
Salim Yusuf
Publication year - 2021
Publication title -
cardiovascular research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.774
H-Index - 219
eISSN - 1755-3245
pISSN - 0008-6363
DOI - 10.1093/cvr/cvab078
Subject(s) - rosuvastatin , medicine , interquartile range , hazard ratio , rosuvastatin calcium , randomized controlled trial , cohort , confidence interval
To examine the association between rosuvastatin and VTE risk, and whether effects vary in different subpopulations stratified by key demographic, cardiovascular disease (CVD) risk factors, and other risk factors associated with VTE.